BE878011Q - Agents broncho-dilatateurs et anti-allergiques a base de xanthine a effet prolonge - Google Patents

Agents broncho-dilatateurs et anti-allergiques a base de xanthine a effet prolonge

Info

Publication number
BE878011Q
BE878011Q BE0/196551A BE196551A BE878011Q BE 878011 Q BE878011 Q BE 878011Q BE 0/196551 A BE0/196551 A BE 0/196551A BE 196551 A BE196551 A BE 196551A BE 878011 Q BE878011 Q BE 878011Q
Authority
BE
Belgium
Prior art keywords
broncho
dilators
xanthine
term
long
Prior art date
Application number
BE0/196551A
Other languages
English (en)
Inventor
J Diamond
Original Assignee
Cooper Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cooper Lab filed Critical Cooper Lab
Application granted granted Critical
Publication of BE878011Q publication Critical patent/BE878011Q/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/196551A 1976-03-31 1979-08-01 Agents broncho-dilatateurs et anti-allergiques a base de xanthine a effet prolonge BE878011Q (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/672,437 US4089959A (en) 1976-03-31 1976-03-31 Long-acting xanthine bronchodilators and antiallergy agents

Publications (1)

Publication Number Publication Date
BE878011Q true BE878011Q (fr) 1979-12-03

Family

ID=24698546

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/196551A BE878011Q (fr) 1976-03-31 1979-08-01 Agents broncho-dilatateurs et anti-allergiques a base de xanthine a effet prolonge

Country Status (2)

Country Link
US (1) US4089959A (fr)
BE (1) BE878011Q (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207321A (en) * 1977-04-02 1980-06-10 Hoechst Aktiengesellschaft Pharmaceutical compositions containing xanthines
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE7810946L (sv) * 1978-10-20 1980-04-21 Draco Ab Metod att behandla kronisk obstruktiv luftvegssjukdom
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
CH643260A5 (fr) * 1980-05-02 1984-05-30 Nestle Sa 1-allyl-3-butyl-8-methylxanthine, procede de preparation et utilisation dans un medicament.
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
US4698144A (en) * 1986-05-15 1987-10-06 The Dow Chemical Company Apparatus for balancing electrolytic cell gas with circulating electrolyte
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5032593A (en) * 1988-07-01 1991-07-16 Marion Merrell Dow Inc. Method of treating bronchoconstriction with 1,3-unsymmetrical straight chain alkyl-substituted 8-phenylxanthines
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
US5658881A (en) * 1994-10-14 1997-08-19 Twk, Inc. Method for topical inhibition of the metabolic activity of cytochrome P450
US5981549A (en) * 1997-02-14 1999-11-09 Synapse Pharmaceutical International Method for controlling or alleviating the symptoms of respiratory disease and allergies
US6403567B1 (en) 1999-06-22 2002-06-11 Cv Therapeutics, Inc. N-pyrazole A2A adenosine receptor agonists
USRE47351E1 (en) 1999-06-22 2019-04-16 Gilead Sciences, Inc. 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
US6815446B1 (en) 1999-08-31 2004-11-09 Vanderbilt University Selective antagonists of A2B adenosine receptors
US6281248B1 (en) 2000-02-16 2001-08-28 Magda Abdel Fattah Ahmed Composition for treating asthma
US20020012946A1 (en) 2000-02-23 2002-01-31 Luiz Belardinelli Method of identifying partial agonists of the A2A receptor
US7683037B2 (en) * 2002-07-29 2010-03-23 Gilead Palo Alto, Inc. Myocardial perfusion imaging method
US20050020915A1 (en) * 2002-07-29 2005-01-27 Cv Therapeutics, Inc. Myocardial perfusion imaging methods and compositions
US8470801B2 (en) 2002-07-29 2013-06-25 Gilead Sciences, Inc. Myocardial perfusion imaging methods and compositions
JP2008517063A (ja) 2004-10-20 2008-05-22 シーブイ・セラピューティクス・インコーポレイテッド Ａ２ａアデノシンレセプターアゴニストの使用
US8262578B1 (en) 2004-11-24 2012-09-11 Pacesetter, Inc. System and method for detecting physiologic states based on intracardiac electrogram signals while distinguishing cardiac rhythm types
US7361146B1 (en) 2004-11-24 2008-04-22 Pacesetter, Inc. System and method for detecting abnormal respiration via respiratory parameters derived from intracardiac electrogram signals
US7435221B1 (en) 2004-11-24 2008-10-14 Pacesetter, Inc. System and method for detecting abnormal respiration based on intracardiac electrogram signals using a pattern recognition device
US7404799B1 (en) 2005-04-05 2008-07-29 Pacesetter, Inc. System and method for detection of respiration patterns via integration of intracardiac electrogram signals
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils
PL1989214T3 (pl) 2006-02-03 2017-07-31 Gilead Sciences, Inc. Proces otrzymywania agonisty receptora adenozynowego a2a i jego polimorfów
US20090081120A1 (en) * 2006-09-01 2009-03-26 Cv Therapeutics, Inc. Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods
BRPI0716174A2 (pt) * 2006-09-01 2013-09-24 Cv Therapeutics Inc mÉtodos e composiÇÕes para aumentar a tolerabilidade de paciente durante mÉtodos de imagem do miocÁrdio.
JP2011502101A (ja) * 2006-09-29 2011-01-20 ギリアード・パロ・アルト・インコーポレイテッド 肺疾患の病歴を有する患者における心筋画像化法
US20080267861A1 (en) * 2007-01-03 2008-10-30 Cv Therapeutics, Inc. Myocardial Perfusion Imaging
CN102164591A (zh) * 2008-09-29 2011-08-24 吉利德科学股份有限公司 速率控制剂和A-2-α受体拮抗剂的组合用于多检测器计算机化断层显像方法
BRPI1013561A8 (pt) * 2009-03-26 2015-09-22 Mapi Pharma Ltd processo para a preparação de alogliptina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2729643A (en) * 1956-01-03 J-disubstmjied and i
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3624215A (en) * 1970-06-25 1971-11-30 Abbott Lab 8-substituted theophyllines as anti-anxiety agents
US3624216A (en) * 1970-06-25 1971-11-30 Abbott Lab 8-substituted theophyllines as anti-inflammatory agents

Also Published As

Publication number Publication date
US4089959A (en) 1978-05-16

Similar Documents

Publication Publication Date Title
BE878011Q (fr) Agents broncho-dilatateurs et anti-allergiques a base de xanthine a effet prolonge
NO148832C (no) Automatisk maale- og utleveringsinnretning
JPS5349545A (en) Model device
BE852737A (fr) Quinoxalinones et quinoxalines
BE851941A (fr) Versterkingsschermen voor gebruik in de rontgenfotografie
SE7512799L (sv) Upphengnings- och uppleggningsanordning
PL202070A1 (pl) Regal oraz zespol regalow
BE850490A (fr) Compositions trincoriales a base de diphenyl-amines et de polyphydroxybenzenes
SE7712707L (sv) Pendelanordning
SE427802B (sv) Lek- och ovningsanordning
JPS5312007A (en) Bearing device
NO773297L (no) Drag- og opphengningsanordning.
BE858172A (fr) Compositions a base de the et leur preparation
JPS52108979A (en) 33substitutedd55phenyll55pyridylhydantoin and antiiarrhythmic agents
JPS52142829A (en) Moving form construction and form device used therefor
JPS53356A (en) Bearing device
SE7713045L (sv) Lunnings- och buntningsslepkerra
SE7601727L (sv) Grund- och holkelement
BE860110A (fr) Agents anti-coccidiens et ovo-larvicides renfermant un amino-alcane
JPS538447A (en) Bearing device
JPS5365542A (en) Bearing device
JPS53355A (en) Bearing device
JPS531742A (en) Bearing device
JPS52135952A (en) Bearing device
JPS5364920A (en) Coupled structure and making device thereof

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BERLEX LABORATORIES INC.

Effective date: 19960831